RECRUITING

Diabetes Education/Skills Training and Social Needs Resolution Intervention

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will test the preliminary efficacy of a nurse case-manager, telephone-delivered intervention that provides diabetes self-management education and skills training and resolves the unmet social needs of older African Americans with poorly controlled type 2 diabetes by randomizing 100 African Americans aged 50 years and older with poorly controlled type 2 diabetes to the Combined Diabetes Education/Skills Training and Social Needs Resolution (DM Social Needs) Intervention (n=50) and usual care (n=50) arms. The aims of this study are: Aim 1: Test the preliminary efficacy of the DM Social Needs intervention on clinical outcomes in older AAs with uncontrolled type 2 diabetes. Aim 2: Test the preliminary efficacy of the DM Social Needs intervention on patient reported outcomes in older AAs with uncontrolled type 2 diabetes.

Official Title

Combined Diabetes Education/Skills Training and Social Needs Resolution Intervention for Older African Americans With Poorly Controlled Type 2 Diabetes (DM Social Needs)

Quick Facts

Study Start:2023-08-01
Study Completion:2025-11
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05935410

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:50 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Age 50 and older;
  2. 2. self-identified as African American or Black;
  3. 3. self-reported diagnosis of T2DM;
  4. 4. HbA1C \>=8% at the screening visit.
  1. 1. self-reported participation in other diabetes clinical trials;
  2. 2. alcohol or drug abuse or dependency as assessed by the CAGE-AID;
  3. 3. Mental confusion at screening assessment suggesting significant dementia;
  4. 4. life expectancy \< 6 months at screening assessment.

Contacts and Locations

Study Contact

Aprill Z Dawson, PhD, MPH
CONTACT
414-955-8828
adawson@mcw.edu
Jennifer A Campbell, PhD, MPH
CONTACT
414-955-8829
jacampbell@mcw.edu

Principal Investigator

Aprill Z Dawson, PhD, MPH
PRINCIPAL_INVESTIGATOR
Medical College of Wisconsin

Study Locations (Sites)

Aprill Dawson
Milwaukee, Wisconsin, 53226
United States

Collaborators and Investigators

Sponsor: Medical College of Wisconsin

  • Aprill Z Dawson, PhD, MPH, PRINCIPAL_INVESTIGATOR, Medical College of Wisconsin

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-08-01
Study Completion Date2025-11

Study Record Updates

Study Start Date2023-08-01
Study Completion Date2025-11

Terms related to this study

Additional Relevant MeSH Terms

  • Type 2 Diabetes